Breaking News Instant updates and real-time market news.

TTWO

Take-Two

$111.05

(0.00%)

09:43
10/25/18
10/25
09:43
10/25/18
09:43

Reviews for Take-Two's new 'Red Dead' very positive, says Baird

Initial metacritic scores for Take-Two Interactive's "Red Dead Redemption 2" are very positive, Baird analyst Colin Sebastian tells investors in a research note. The game currently has a 97 rating on metacritic.com for the PS4, on par with the last major release for the studio's blockbuster "Grand Theft Auto" franchise and slightly higher than the prior "Red Dead" title, the analyst points out. Sebastian says the early reviews provide him with additional confidence in his unit forecasts. The analyst currently anticipates 22M units for fiscal 2019, with upside potential to the 25M unit level. He maintains an Outperform rating on Take-Two shares with a $140 price target.

  • 15

    Nov

TTWO Take-Two
$111.05

(0.00%)

10/22/18
MSCO
10/22/18
NO CHANGE
MSCO
Morgan Stanley says publishers in 'win-win' situation as consoles move to cloud
Morgan Stanley analyst Brian Nowak sees changes coming to the $53B global console gaming market as the business model transitions toward subscription pricing and cloud delivery. The transition will lead to 2% CAGR console gaming revenue growth from 2017-2025, but gross profit growth accelerating to 6%, Nowak estimates. He believes game publishers such as Activision Blizzard (ATVI), Electronic Arts (EA) and Take-Two (TTWO) will likely need to partner and bundle content to drive material consumer adoption, but he sees them being in a "win-win" position, because even if the console makers or other aggregators drive the cloud transition, the leading publishers can still benefit from expansion in the player base, Nowak tells investors. While console players Microsoft (MSFT) and Sony (SNE) have the most at risk from these changes, they are also positioned best to build and grow game subscription services, Nowak added.
10/22/18
PIPR
10/22/18
NO CHANGE
PIPR
Teen survey positive for console publisher group, says Piper Jaffray
Piper Jaffray analyst Michael Olson says his firm's 36th semi-annual survey of 8,600 teens shows that video game console ownership was up, with 83% claiming to own a current gen console or expecting to buy one. Spending on video games also increased, from 13% of male teen budgets in spring 2018 to 14% currently, Olson tells investors in a research note. Further, he points out that a growing number of teens watch others play games via YouTube and Twitch, while the number of teens who play mobile games fell from the spring survey. The analyst views the data as positive for the console publisher group Activision Blizzard (ATVI), Electronic Arts (EA) and Take-Two (TTWO), and neutral for mobile game companies Zynga (ZNGA) and Glu Mobile (GLUU).
10/19/18
PIPR
10/19/18
NO CHANGE
PIPR
Piper Jaffray lists 'stocks to own' following tech sector sell-off
Piper Jaffray's tech analysts highlighted their "stocks to own" following the recent sell-off in the technology sector. The firm's top picks across each coverage universe include Amazon.com (AMZN), Broadcom (AVGO), Salesforce (CRM), Finisar (FNSR), Microchip (MCHP), Mellanox (MLNX), ServiceNow (NOW), Nutanix (NTNX), Proofpoint (PFPT), Impinj (PI), Take-Two (TTWO) and Twilio (TWLO).
10/19/18
PIPR
10/19/18
NO CHANGE
PIPR
September NPD video game software sales dropped 8%, says Piper Jaffray
Overall September NPD video game software sales were down 8% year-over-year despite launches of strong franchises, Piper Jaffray analyst Michael Olson tells investors in a research note. The top title for Sept. was Sony's (SNE) Spiderman followed by Take-Two's (TTWO) NBA 2K19, Ubisoft's Assassin's Creed and Electronic Arts' (EA) FIFA 19, the analyst points out. Olson views the Sept. NPD data as less relevant for Activision Blizzard (ATVI) given his expectation for greater than 75% of its revenue coming from digital sources. He maintains Overweight ratings on Activision, Electronic Arts and Take-Two.

TODAY'S FREE FLY STORIES

BIIB

Biogen

$230.70

1.49 (0.65%)

16:24
05/20/19
05/20
16:24
05/20/19
16:24
Initiation
Biogen initiated  »

Biogen initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

SWI

SolarWinds

$19.16

0.04 (0.21%)

16:23
05/20/19
05/20
16:23
05/20/19
16:23
Syndicate
SolarWinds files to sell 17.25M shares of common stock »

JPMorgan, Goldman Sachs,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 23

    May

AMGN

Amgen

$168.36

-1.5 (-0.88%)

16:21
05/20/19
05/20
16:21
05/20/19
16:21
Initiation
Amgen initiated  »

Amgen initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 31

    May

GM

General Motors

$36.98

-0.02 (-0.05%)

16:21
05/20/19
05/20
16:21
05/20/19
16:21
Periodicals
GM plans wind-down of Maven car-sharing service in some cities, WSJ says »

According to the Wall…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 04

    Jun

  • 05

    Jun

  • 01

    Aug

DBVT

DBV Technologies

$8.98

-0.21 (-2.29%)

, AIMT

Aimmune

$19.68

-0.41 (-2.04%)

16:20
05/20/19
05/20
16:20
05/20/19
16:20
Initiation
DBV Technologies, Aimmune initiated  »

Aimmune assumed with an…

DBVT

DBV Technologies

$8.98

-0.21 (-2.29%)

AIMT

Aimmune

$19.68

-0.41 (-2.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 13

    Sep

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
05/20/19
05/20
16:20
05/20/19
16:20
Options
Closing CBOE SPX and VIX Index summary for May 20th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVNA

Carvana

$67.17

-0.935 (-1.37%)

16:19
05/20/19
05/20
16:19
05/20/19
16:19
Syndicate
Carvana files to sell 3.5M shares of Class A common stock »

Wells Fargo Securities,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

INCY

Incyte

$76.83

-0.41 (-0.53%)

16:19
05/20/19
05/20
16:19
05/20/19
16:19
Initiation
Incyte initiated  »

Incyte initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 24

    May

  • 31

    May

  • 05

    Jun

  • 13

    Jun

GOOG

Alphabet

$1,138.33

-23.56 (-2.03%)

, GOOGL

Alphabet Class A

$1,145.28

-23 (-1.97%)

16:19
05/20/19
05/20
16:19
05/20/19
16:19
On The Fly
Fly Intel: Wall Street's top stories for Monday »

Stocks have started the…

GOOG

Alphabet

$1,138.33

-23.56 (-2.03%)

GOOGL

Alphabet Class A

$1,145.28

-23 (-1.97%)

INTC

Intel

$43.58

-1.3 (-2.90%)

QCOM

Qualcomm

$76.61

-4.91 (-6.02%)

XLNX

Xilinx

$101.05

-3.71 (-3.54%)

AVGO

Broadcom

$272.59

-17.27 (-5.96%)

S

Sprint

$7.34

1.165 (18.87%)

TMUS

T-Mobile

$78.32

2.93 (3.89%)

F

Ford

$10.28

-0.01 (-0.10%)

FB

Facebook

$182.71

-2.56 (-1.38%)

QGEN

Qiagen

$38.05

0.96 (2.59%)

MDCO

The Medicines Co.

$34.25

1.24 (3.76%)

DISH

Dish

$33.24

-2.095 (-5.93%)

SATS

EchoStar

$41.97

1.55 (3.83%)

PDD

Pinduoduo

$20.78

-1.91 (-8.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 20

    May

  • 22

    May

  • 24

    May

  • 30

    May

  • 30

    May

  • 31

    May

  • 03

    Jun

  • 05

    Jun

  • 13

    Jun

  • 13

    Jun

  • 19

    Jun

  • 19

    Jun

  • 20

    Jun

  • 24

    Jul

  • 25

    Jul

  • 31

    Jul

  • 06

    Aug

  • 23

    Oct

  • 27

    Oct

GH

Guardant Health

$78.29

2.13 (2.80%)

16:18
05/20/19
05/20
16:18
05/20/19
16:18
Syndicate
Guardant Health files to sell 4.5M shares of common stock »

JPMorgan and BofA/Merrill…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 05

    Jun

  • 12

    Jun

  • 18

    Jun

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
05/20/19
05/20
16:17
05/20/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INSM

Insmed

$28.08

-1.08 (-3.70%)

16:16
05/20/19
05/20
16:16
05/20/19
16:16
Syndicate
Insmed files to sell $250M of common stock »

Morgan Stanley & Co.,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
05/20/19
05/20
16:16
05/20/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEO

NeoGenomics

$23.19

0.22 (0.96%)

16:15
05/20/19
05/20
16:15
05/20/19
16:15
Syndicate
Breaking Syndicate news story on NeoGenomics »

NeoGenomics files $150M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 05

    Jun

  • 06

    Jun

  • 13

    Nov

BKNG

Booking Holdings

$1,751.62

-35.11 (-1.97%)

16:15
05/20/19
05/20
16:15
05/20/19
16:15
Initiation
Booking Holdings initiated  »

Booking Holdings assumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

TRIP

TripAdvisor

$45.01

0.01 (0.02%)

16:13
05/20/19
05/20
16:13
05/20/19
16:13
Upgrade
TripAdvisor rating change  »

TripAdvisor upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 22

    May

  • 11

    Jun

EXPE

Expedia

$116.48

0.22 (0.19%)

16:13
05/20/19
05/20
16:13
05/20/19
16:13
Initiation
Expedia initiated  »

Expedia assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

MGM

MGM Resorts

$25.34

-0.54 (-2.09%)

16:11
05/20/19
05/20
16:11
05/20/19
16:11
Conference/Events
MGM Resorts participates in a conference call with UBS »

Leisure, Gaming &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 29

    May

KR

Kroger

$24.06

-0.165 (-0.68%)

16:10
05/20/19
05/20
16:10
05/20/19
16:10
Upgrade
Kroger rating change  »

Kroger upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

CLVS

Clovis

$16.35

-0.68 (-3.99%)

16:08
05/20/19
05/20
16:08
05/20/19
16:08
Hot Stocks
Clovis says Rubraca increased symptom-free period in ovarian cancer patients »

Clovis Oncology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 06

    Jun

VRSK

Verisk Analytics

$141.45

-0.56 (-0.39%)

16:07
05/20/19
05/20
16:07
05/20/19
16:07
Conference/Events
Verisk Analytics management to meet with Cantor Fitzgerald »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

  • 05

    Jun

MRVL

Marvell

$21.73

-0.885 (-3.91%)

16:06
05/20/19
05/20
16:06
05/20/19
16:06
Hot Stocks
Marvell to acquire Avera Semiconductor for $650M in cash »

Marvell announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

VNE

Veoneer

$18.84

-0.03 (-0.16%)

16:06
05/20/19
05/20
16:06
05/20/19
16:06
Syndicate
Breaking Syndicate news story on Veoneer »

Veoneer files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

OCUL

Ocular Therapeutix

$3.35

-0.11 (-3.18%)

16:06
05/20/19
05/20
16:06
05/20/19
16:06
Hot Stocks
Ocular Therapeutix says OTX-TP failed to meet primary endpoint in Phase 3 trial »

Ocular Therapeutix…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

  • 10

    Nov

CBAY

CymaBay

$12.37

-0.24 (-1.90%)

16:05
05/20/19
05/20
16:05
05/20/19
16:05
Hot Stocks
CymaBay announces results related to seladelpar clinical development program »

CymaBay Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.